Sperm Gene Expression Screening for Faster MAP Selection

The patent applies preliminary action by performing morphological evaluation of spermatozoa before the actual ICSI procedure. Sperm samples are pre-screened using automated image analysis systems that capture and evaluate sperm morphology at high magnification in advance, allowing clinicians to identify suitable spermatozoa beforehand and reduce the time required during the actual injection procedure.

The patent replaces manual microscopic examination with automated image analysis systems. These systems use digital imaging and computer-based morphological evaluation to objectively assess spermatozoa, eliminating the time-consuming manual inspection process while maintaining or improving selection accuracy through consistent, standardized criteria.

The patent replaces subjective manual evaluation by biologists with automated image analysis systems that apply standardized morphological criteria consistently. These systems capture sperm images and automatically assess morphological features using predefined parameters, eliminating inter-observer variability and ensuring uniform evaluation standards across different samples and operators.

The patent implements feedback mechanisms where the automated system continuously refines its evaluation based on established morphological criteria and known successful outcomes. The system provides objective, quantifiable measurements of sperm morphology that can be tracked and validated, creating a feedback loop that ensures consistent application of selection standards.

The patent applies local quality by performing high-magnification morphological evaluation only for sperm samples that require enhanced selection, rather than universally applying the most complex methodology to all cases. The system allows clinicians to select the appropriate level of evaluation based on individual patient needs, sample characteristics, and clinical indications, optimizing resource utilization.

The patent enables flexible adjustment of evaluation parameters and magnification levels based on specific clinical requirements. The automated system can adapt its assessment criteria and imaging parameters to match the particular characteristics of each sperm sample and clinical scenario, providing optimized selection without unnecessarily increasing complexity for all cases.